Company Filing History:

5 out of 32

Meiji Seika Kabushiki Kaisha

patents

4 out of 314

Taisho Pharmaceutical Co., Ltd.

patents

4 out of 382

Meiji Seika Kaisha, Ltd.

patents

4. 3 out of 107

Meiji Seika Pharma Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 1997-2015

Loading Chart...

12 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 9139609 - C-4″ position substituted macrolide derivative (2015-09-22),

2. 8299035 - 10a-azalide compound having 4-membered ring structure (2012-10-30),

3. 8293715 - 10a-Azalide compound crosslinked at 10a- and 12-positions (2012-10-23),

4. 8097708 - 10a-Azalide compound (2012-01-17),

5. 7365174 - Azalide and azalactam derivatives and method for producing the same (2008-04-29),

6. 6660718 - 3-modified leucomycin derivatives (2003-12-09),

7. 6472397 - Nitrogen-containing heterocyclic compounds having antiplatelet aggregation effect and medicinal use thereof (2002-10-29),

8. 5958981 - .gamma.-diketone compounds with inhibitory activity against platelet (1999-09-28),

9. 5814636 - Compounds with platelet aggregation inhibitor activity (1998-09-29),

10. 5760053 - .gamma.-Diketone compounds with inhibitory activity against platelet (1998-06-02),

11. 5698692 - Compound with platelet aggregation inhibitor activity (1997-12-16),

12. 5594004 - Compound with platelet aggregation inhibitor activity (1997-01-14),

Title: The Innovative Contributions of Tomoaki Miura

Introduction

Tomoaki Miura is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing macrolide compounds. With a total of 12 patents to his name, Miura's work has been instrumental in addressing antibiotic resistance.

Latest Patents

Among his latest patents is the "C-4″ position substituted macrolide derivative." This macrolide compound is effective against erythromycin-resistant bacteria, including resistant pneumococci, streptococci, and mycoplasmas. Another notable patent is the "10a-azalide compound having a 4-membered ring structure." This compound is crosslinked at the 10- and 12-positions and is also effective against erythromycin-resistant bacteria.

Career Highlights

Miura has worked with several reputable companies in the pharmaceutical industry, including Meiji Seika Kabushiki Kaisha and Taisho Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to develop innovative solutions to pressing health issues.

Collaborations

Throughout his career, Miura has collaborated with notable colleagues, including Eiki Shitara and Kiyoaki Katano. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Tomoaki Miura's contributions to pharmaceutical innovation are noteworthy, particularly in the fight against antibiotic resistance. His patents reflect a commitment to improving healthcare through scientific advancement.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.